Session

Overview: Reirradiation of prostate cancer addresses a critical aspect of managing recurrent disease post-primary radiotherapy of the prostate. We will evaluate the benefits and limitations of various reirradiation techniques, such as brachytherapy, EBRT, and SBRT, focusing on their effectiveness and potential toxicities. You will be able to focus on selecting suitable reirradiation strategies based on patient selection, precise target delineation, initial treatment modalities, and acute and late GI and GU toxicities. Additionally, the session will explore focal therapy's role in reducing toxicity for recurrent lesions, supported by data and the importance of advanced imaging for targeted reirradiation. We aim to provide a suitable understanding of reirradiation options, enhancing patient care in prostate cancer treatment.